This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 211096-49-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
211096-49-0 / 1-(2-bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea
Standard CAS: 211096-49-0
Multi CAS: No
Basic Information
copy
CAS
211096-49-0 copy
Multi CAS
No copy
Molecular Formula
C14H9BrN6O copy
Molecular Weight
357.160000 copy
Exact Mass
356.002120 copy
SMILES
C1=CC=C(C(=C1)NC(=O)NC2=CC=C(C3=NNN=C23)C#N)Br copy
InChI
InChI=1S/C14H9BrN6O/c15-9-3-1-2-4-10(9)17-14(22)18-11-6-5-8(7-16)12-13(11)20-21-19-12/h1-6H,(H2,17,18,22)(H,19,20,21) copy
InChIKey
SEDUMQWZEOMXSO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
22 copy
Aromatic heavy atom count
15 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
H-bond donors
3 copy
Molar refractivity
85.39 copy
TPSA
106.49 copy
LogP / Solubility
WLOGP
3.24 copy
MLOGP
2.87 copy
XLogP3
2 copy
Consensus LogP
2.7 copy
Log S (ESOL)
-4.47 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-4.83 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.91 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.6 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy